Immunotherapy: Hope, Hurdles, and a Clever Disguise Immunotherapies stand as one of the most promising paths in modern cancer treatment. Their main goal? To help the body’s own immune system hunt down ...

Add Yahoo as a preferred source to see more of our stories on Google. Drugs commonly used to treat enlarged prostate symptoms may also protect against a common form of dementia, scientists believe.

Add Yahoo as a preferred source to see more of our stories on Google. An innovative new drug being trialled to tackle certain cancers could also benefit patients with advanced prostate cancer whose ...

Men diagnosed with high-risk localized prostate cancer now have trial-level evidence that adding the drug apalutamide to ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research published in ...

A new cancer drug may be able to inhibit both tumor growth and the spread of aggressive prostate cancer. This is shown in a ...

New research sheds light on the significance of the glucocorticoid receptor in drug-resistant prostate cancer, showing that the development of drug resistance could be prevented by limiting the ...

“Around 35,000 people die in the U.S. from advanced prostate cancer each year. For these patients, their cancer has become resistant to all current forms of therapy,” says Dr. Stephen Plymate, ...

A new drug combo is offering hope for men with advanced prostate cancer. Adding the targeted cancer drug niraparib to hormone therapy reduced the risk of prostate tumor growth and slowed symptom ...

An experimental drug for advanced prostate cancer has shown preliminary success in the first and second phases of clinical trials, shrinking tumors in the lab and reducing signs of the disease in ...

Johnson & Johnson's Erleada drug, combined with hormone therapy, significantly reduces the risk of prostate cancer spread and ...

NEW YORK (Reuters Health) - Men taking cholesterol-lowering medication may be less likely to get prostate cancer than those not on the drugs, suggests a new study. They are also less likely to wind up ...